![](/img/cover-not-exists.png)
P-306 * A phase II biopsy-driven study to identify biomarkers predictive of clinical response to second-line regorafenib in patients with metastatic colorectal cancer
Schab, A., Abdelsalam, M., Aubin, F., Langleben, A., Couture, F., Gologan, A., Constantin, A., Camlioglu, E., Hoffert, C., Batist, G., Kavan, P.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv233.303
Date:
June, 2015
File:
PDF, 33 KB
english, 2015